Augmentiqs Receives U.S. Patent

Augmentiqs Receives U.S. Patent

After an extensive waiting period, Augmentiqs received official notice of a U.S. patent. The patent is awarded for innovation and usefulness, highlighting the unique method via which Augmentiqs can improve pathology. Gabe Siegel, Augmentiqs CEO and co-founder,...
Collaboration on NIH R01 Grant

Collaboration on NIH R01 Grant

 NIH is Calling for Research into Cancer Image Interpretation, and Augmentiqs is the Most Capable Tool for the Job.Augmentiqs is looking to collaborate with researchers in what is arguably one of the most fascinating and unexplored areas of pathology.NIH (link to...
Discounted Price for 3rd Ocular Cameras

Discounted Price for 3rd Ocular Cameras

 Limited Time Offer – Special Discount on 3rd Ocular Cameras with Augmentiqs Digital Pathology & Telepathology SoftwareAugmentiqs was started with the goal of delivering all the potential of digital pathology within the existing microscope and pathology...
July Newsletter

July Newsletter

 Keeping you up to date with all the latest news in augmented reality microscopy and microscope based digital pathologySpecial Offer for 3rd Ocular Camera with Telepathology SoftwareNew ProductsAugmented Reality for Diagnosing Breast Cancer – Groundbreaking...
ARM Microscopy Study for Ki-67 Scoring

ARM Microscopy Study for Ki-67 Scoring

 The First-of-its-Kind ARM Microscopy Study for Ki-67 Scoring with Augmentiqs was Conducted at UPMC by Dr. Liron Pantanowitz and published in the May 2020 Journal of Cancer CytopathologyAccepted and published in the Journal of Cancer Cytopathology, the non-sponsored...